Have you or a loved one
been diagnosed with pancreatic cancer?
You are not Alone.
Pancreatic Cancer Alliance – Support in the fight against pancreatic cancer
The mission of the Pancreatic Cancer Alliance (PCA) is to support you in your fight against pancreatic cancer. We are a local organization, leading the way in Central Massachusetts, to support patients diagnosed with this devastating illness and families affected by pancreatic cancer.
On this web site you'll find links to resources available on the Internet, information on research being undertaken at the University of Massachusetts Medical School and the UMass Memorial Cancer Center of Excellence, links to news stories about the struggle as well as information on fundraising events and how you can support research to bring the kinds of advances needed to conquer this underfunded disease.
In 2016, pancreatic cancer moved from the fourth leading cause of cancer-related death in the U.S. to the third, surpassing breast cancer. In 2019, an estimated 56,770 Americans will be diagnosed with pancreatic cancer, and approximately 45,750 of those newly diagnosed will not survive. Pancreatic cancer is now more deadly than prostate and breast cancer. Seventy-one percent of patients will die within the first year of diagnosis. Pancreatic cancer is the only major cancer with a five-year relative survival rate in the single digits, at just 9 percent. While overall cancer incidence and death rates are declining, the incidence and death rates for pancreatic cancer are increasing. Pancreatic cancer is projected to move past colorectal cancer to become the second leading cause of cancer-related deaths in the U.S. behind lung cancer in 2020.
Together we can do better
The Cancer Research Center at the University of Massachusetts Medical School in Worcester has accepted the challenge of pancreatic cancer research and to use that research to help patients as soon as possible — with pancreatic cancer there is no time to wait.
Alliance funds clinical trials program
Money raised by the PCA is being used to fund a dedicated pancreatic cancer clinical trials program at UMass and to support research through the international Pancreatic Cancer Research Team (www.pcrt.org) to open clinical trials at UMass. Click here to see how you can help.
High Risk Pancreatic Clinic Opens
The UMass High Risk Pancreatic clinic is seeing patients. Pancreas clinic services include:
- Risk assessment
- Genetic counseling
- Ongoing surveillance
UMass Pancreas Program to optimize patient care & outcomes
The UMass Pancreas Program was established as a multidisciplinary group seeking to advance pancreatic cancer treatment in the Northeast. As a member of the UMass Pancreas Program, Dr. Jennifer LaFemina, is assembling an extraordinary research and medical team for the UMass Pancreas Program. By integrating groundbreaking basic science and patient-oriented research with improved access to innovative clinical trials and cutting-edge therapies, the UMass Pancreas Program aspires to optimize patient care and outcomes.
World Pancreatic Cancer Coalition
In 2016, The PCA became a founding member of the World Pancreatic Cancer Coalition (WPCC). At the time, there were 42 member organizations from 20 countries. Now, 33 countries are represented by 79 member organizations that meet annually to discuss best practices, advancements and share resources.
Links of note
Stories of hope and survival from Pancreatica.org Read about long-term pancreatic cancer survivors.